Cromolyn (Oral Inhalation) and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Cromolyn (Oral Inhalation) and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cromolyn
Brand name: Gastrocrom
Synonyms: Cromolyn sodium
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cromolyn (Oral Inhalation)-Insulin glargine, recombinant Subcutaneous
- Cromolyn (Oral Inhalation)-Insulin glulisine
- Cromolyn (Oral Inhalation)-Insulin Glulisine (Cartridges and Pens)
- Cromolyn (Oral Inhalation)-Insulin Glulisine (Vials)
- Cromolyn (Oral Inhalation)-Insulin glulisine Subcutaneous
- Cromolyn (Oral Inhalation)-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Cromolyn (Systemic)
- Insulin glargine and lixisenatide Subcutaneous-Cromolyn Capsules
- Insulin glargine and lixisenatide Subcutaneous-Cromolyn Inhalation, oral/nebulization
- Insulin glargine and lixisenatide Subcutaneous-Cromolyn Oral Concentrate
- Insulin glargine and lixisenatide Subcutaneous-Cromolyn sodium
- Insulin glargine and lixisenatide Subcutaneous-Cromolyn sodium inhalation